Brain cell reservoirs of latent virus in presymptomatic HIV-infected individuals
about
HIV-1 Tat C-mediated regulation of tumor necrosis factor receptor-associated factor-3 by microRNA 32 in human microgliaMinireview: From the bench, toward the clinic: therapeutic opportunities for cannabinoid receptor modulationTargeting the Brain Reservoirs: Toward an HIV CureAre T cells the only HIV-1 reservoir?Dopamine receptor activation increases HIV entry into primary human macrophagesIn vivo dynamics of innate immune sentinels in the CNS.Proteasome inhibitors act as bifunctional antagonists of human immunodeficiency virus type 1 latency and replication.Opioids and Opioid Maintenance Therapies: Their Impact on Monocyte-Mediated HIV Neuropathogenesis.Productive HIV-1 infection of human cervical tissue ex vivo is associated with the secretory phase of the menstrual cycle.Macrophages and their relevance in Human Immunodeficiency Virus Type I infection.Is the central nervous system a reservoir of HIV-1?Tissue myeloid cells in SIV-infected primates acquire viral DNA through phagocytosis of infected T cells.SAHA enhances synaptic function and plasticity in vitro but has limited brain availability in vivo and does not impact cognition.Measuring glutathione redox potential of HIV-1-infected macrophages.Evidence for cFMS signaling in HIV production by brain macrophages and microglia.Cerebrospinal fluid (CSF) CD8+ T-cells that express interferon-gamma contribute to HIV associated neurocognitive disorders (HAND)Humanized mouse models for HIV-1 infection of the CNS.HIV eradication symposium: will the brain be left behind?Role of the macrophage in HIV-associated neurocognitive disorders and other comorbidities in patients on effective antiretroviral treatment.Modeling HIV-associated neurocognitive disorders in mice: new approaches in the changing face of HIV neuropathogenesisThe dual action of poly(ADP-ribose) polymerase -1 (PARP-1) inhibition in HIV-1 infection: HIV-1 LTR inhibition and diminution in Rho GTPase activityHIV persistence in the setting of antiretroviral therapy: when, where and how does HIV hide?Temporal transcriptional response to latency reversing agents identifies specific factors regulating HIV-1 viral transcriptional switchWhen human immunodeficiency virus meets chemokines and microglia: neuroprotection or neurodegeneration?Opiate drug use and the pathophysiology of neuroAIDS.Early Antiretroviral Therapy Is Associated with Lower HIV DNA Molecular Diversity and Lower Inflammation in Cerebrospinal Fluid but Does Not Prevent the Establishment of Compartmentalized HIV DNA PopulationsΒ-funaltrexamine inhibits chemokine (CXCL10) expression in normal human astrocytesAttenuation of HIV-1 replication in macrophages by cannabinoid receptor 2 agonists.Proliferation of Perivascular Macrophages Contributes to the Development of Encephalitic Lesions in HIV-Infected Humans and in SIV-Infected Macaques.RON receptor tyrosine kinase, a negative regulator of inflammation, is decreased during simian immunodeficiency virus-associated central nervous system diseaseCompartmentalized HIV rebound in the central nervous system after interruption of antiretroviral therapy.Enhanced human immunodeficiency virus Type 1 expression and neuropathogenesis in knockout mice lacking Type I interferon responses.HIV induces expression of complement component C3 in astrocytes by NF-κB-dependent activation of interleukin-6 synthesis.Tissue-resident macrophages can contain replication-competent virus in antiretroviral-naive, SIV-infected Asian macaques.Astrocytic expression of HIV-1 viral protein R in the hippocampus causes chromatolysis, synaptic loss and memory impairment.HIV-associated neurocognitive disorders: recent advances in pathogenesis, biomarkers, and treatment.Immune Responses in the Central Nervous System Are Anatomically Segregated in a Non-Human Primate Model of Human Immunodeficiency Virus Infection.Interactions between prostaglandins, leukotrienes and HIV-1: possible implications for the central nervous system.Is specific HIV eradication from the brain possible or needed?DNA cleavage enzymes for treatment of persistent viral infections: recent advances and the pathway forward.
P2860
Q21245231-DF4A20C1-C5D4-4830-AC0D-C4BA30968327Q26829111-CD67B876-2575-4139-86B1-BE63070E1DB9Q28075694-93C616F6-6F73-4519-9472-F2F486944F99Q28078850-EDB51791-A21F-47C8-AFBD-7A5F81596518Q28543414-0C6B5D61-803F-488A-9D24-D4A161713D87Q30547038-6BA06D03-0CCD-4CD6-8638-A353DBEAF47FQ33589167-0FDCBF44-27D1-4880-9B2C-839B96BCC461Q33842214-C3AC9A72-A6DE-46F9-AF0A-69D6880A5D54Q34127684-E58D060C-8861-4FCD-AB90-10996BA4B28DQ34303855-43F39CA2-E9B2-4BE3-B5AB-EB2F53455F81Q34434339-7F6D3853-449B-4014-8A79-B5BADCA4927CQ34561884-5455DFDD-08AC-4CBA-8397-86FDB3DB5452Q34905146-040D21B0-471D-433E-8628-0892B09AA9A6Q34958392-B1EA0E5A-FC53-4CCC-9E8E-721D54725330Q35009692-EE7ACF02-C2F0-46AF-8776-F646035FAD55Q35125862-DE4E8DBE-0B1D-4FE8-98B8-35BA98C87E7AQ35567215-86DF6466-928F-4FAC-ABED-BE9517B641EDQ35607587-3E3FD3B3-5D48-48FD-8B8A-602092EADF56Q35652578-62E660D4-3CC1-4EEA-A840-23A87BE9C625Q35921136-81B8F047-FCE3-4CC2-9DAC-31402D50342DQ35992296-AF679008-339F-4132-9143-B98AB05285AEQ36121883-FEA44ECF-F360-45E8-88C3-F9E86C6B8196Q36125264-CB1BBA31-1DC0-4EAD-9968-97D2B2441D62Q36188164-EDC6BE4B-C999-43BB-BDB5-5DA6D0CEB3FBQ36201412-55F3C33D-9390-4C0F-AED7-A7570CED02CAQ36238501-D130BE51-85AB-496B-B31B-AF8C900DF87FQ36703869-3247E8D5-9FED-4BCA-BF71-32412C057B8BQ36775401-25BAA887-2814-4B87-A69B-5540F7AD691CQ37244320-97A96CFB-073B-410F-9EDC-7EB39F150EDEQ37284227-C27E5515-8C34-4AFF-BD81-E6B1F74C6F6DQ37354047-96DB0316-FAD8-4E5A-A076-9082DD3FF334Q37410928-01393044-DAD5-49A6-B282-44B04351394CQ37607835-59A54B04-7947-4ADC-8F83-09AE17DB1564Q37646891-1167B0C1-B3BA-4163-ADFF-B2A48ED2081EQ37714669-2C18E56D-F70C-4133-A9F8-5E1AC62C26D1Q37720509-D1775D6F-A0AE-4C2D-9C7A-B5AAD0F533C4Q37727880-C85FC080-88FB-40AF-A632-0D18313361D9Q37974980-C82D069A-73A1-4599-9265-B30EA1C80552Q38071699-19EB9204-CF4A-4C59-8035-556D750AEEF0Q38184158-F50F6FE1-3F3D-439B-8CED-35884DD66A16
P2860
Brain cell reservoirs of latent virus in presymptomatic HIV-infected individuals
description
2011 nî lūn-bûn
@nan
2011 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Brain cell reservoirs of latent virus in presymptomatic HIV-infected individuals
@ast
Brain cell reservoirs of latent virus in presymptomatic HIV-infected individuals
@en
Brain cell reservoirs of latent virus in presymptomatic HIV-infected individuals
@nl
type
label
Brain cell reservoirs of latent virus in presymptomatic HIV-infected individuals
@ast
Brain cell reservoirs of latent virus in presymptomatic HIV-infected individuals
@en
Brain cell reservoirs of latent virus in presymptomatic HIV-infected individuals
@nl
prefLabel
Brain cell reservoirs of latent virus in presymptomatic HIV-infected individuals
@ast
Brain cell reservoirs of latent virus in presymptomatic HIV-infected individuals
@en
Brain cell reservoirs of latent virus in presymptomatic HIV-infected individuals
@nl
P2093
P2860
P1476
Brain cell reservoirs of latent virus in presymptomatic HIV-infected individuals
@en
P2093
Catherine L Cherry
Catriona A McLean
Jeanne E Bell
Katherine A Thompson
P2860
P304
P356
10.1016/J.AJPATH.2011.06.039
P407
P577
2011-08-24T00:00:00Z